ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer's Disease

被引:0
|
作者
Seleri, Sheila [1 ]
Brangman, Sharon [2 ]
Henderson, J. Neil [3 ]
Parker, Monica [4 ]
Monroe, Stephanie [5 ]
Mintzer, Jacobo [6 ]
Wise-Brown, Alexandria [1 ]
Grundman, Michael [7 ]
Smith, Janice [8 ]
Doody, Rachelle [8 ]
Lin, Helen [1 ]
Assman, Beverly [1 ]
Rippon, Gregory [1 ]
机构
[1] Genentech Inc, Roche Grp, San Francisco, CA USA
[2] SUNY Upstate Med Univ, Syracuse, NY USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Emory Univ, Sch Med, Goizueta Alzheimers Dis Res Ctr, Atlanta, GA USA
[5] UsAgainstAlzheimers, Washington, DC USA
[6] Med Univ South Carolina, Charleston, SC USA
[7] Global R&D Partners LLC, San Diego, CA USA
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
关键词
D O I
10.1212/WNL.0000000000203813
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S26.006
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Epidemiological evolutive study of moderate to severe Alzheimer's Disease (AD) in Spain (5E Study).: 12 months follow-up evaluation
    García, AF
    Ortiz, LA
    Bertrán, JM
    Gregorio, PG
    González, AM
    Rabes, C
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S285 - S285
  • [42] Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer's Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD
    Hey, John
    Abushakra, Susan
    Blennow, Kaj
    Scheltens, Philip
    Hort, Jakub
    Sheardova, Katerina
    Prins, Niels
    Rutgers, Sterre
    Dautzenberg, Paul
    Pazdera, Ladislav
    Kesslak, Patrick
    Mandelbaum, Rosalind
    Power, Aidan
    Tolar, Martin
    NEUROLOGY, 2023, 100 (17)
  • [43] Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study
    Anckaerts, Cynthia
    Blockx, Ines
    Summer, Priska
    Michael, Johanna
    Hamaide, Julie
    Kreutzer, Christina
    Boutin, Herve
    Couillard-Despres, Sebastien
    Verhoye, Marleen
    Van der Linden, Annemie
    NEUROBIOLOGY OF DISEASE, 2019, 124 : 93 - 107
  • [44] A pilot study on mapping structural and functional connectivity in early Alzheimer's disease(AD) in comparison to stable mild cognitive impairment (MCI) and healthy controls
    Nanda, S.
    Menon, R.
    Kesavadas, C.
    Kumari, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 766 - 767
  • [45] Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)
    Robinson, Rebecca L.
    Rentz, Dorene M.
    Andrews, Jeffrey Scott
    Zagar, Anthony
    Kim, Yongin
    Bruemmer, Valerie
    Schwartz, Ronald L.
    Ye, Wenyu
    Fillit, Howard M.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (02) : 437 - 450
  • [46] Targeting Default Mode Network Dysfunction in Persons at Risk of Alzheimer's Disease with Transcranial Magnetic Stimulation (NEST4AD): Rationale and Study Design
    Pievani, Michela
    Mega, Anna
    Quattrini, Giulia
    Guidali, Giacomo
    Ferrari, Clarissa
    Cattaneo, Annamaria
    D'Aprile, Ilari
    Mascaro, Lorella
    Gasparotti, Roberto
    Corbo, Daniele
    Brignani, Debora
    Bortoletto, Marta
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (04) : 1877 - 1889
  • [47] Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study
    Nagata, Tomoyuki
    Shinagawa, Shunichiro
    Yoshida, Kazunari
    Noda, Yoshihiro
    Shigeta, Masahiro
    Mimura, Masaru
    Nakajima, Shinichiro
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (02)
  • [48] Design, synthesis, biological evaluation, and docking study of novel dualacting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease
    Ghotbi, Golaleh
    Mahdavi, Mohammad
    Najafi, Zahra
    Moghadam, Farshad Homayouni
    Hamzeh-Mivehroud, Maryam
    Davaran, Soodabeh
    Dastmalchi, Siavoush
    BIOORGANIC CHEMISTRY, 2020, 103
  • [49] HARBOR: ABBV-916 In Subjects With Early Alzheimer's Disease Combined Multiple-Ascending Dose/Proof-Of-Concept Study Design
    Watson, David
    Lynch, Shau Yu
    Florian, Hana
    Wang, Deli
    Bachhav, Sagar
    Boiser, Joey
    Bannon, Anthony
    Stage, Edwin
    Graff, Ole
    NEUROLOGY, 2023, 100 (17)
  • [50] Retrospective Evaluation of Constructional Praxis Measurements Among APOE4(-) Subjects Enrolled in the Study of AC-1202 (Axona®) in Mild to Moderate Alzheimer's Disease (AD)
    Crumpacker, David W.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 20 (03): : S129 - S129